Jason Butler analyst

Currently out of the existing stock ratings of Jason Butler, 371 are a BUY (96.36%), 13 are a HOLD (3.38%), 1 are a SELL (0.26%).

Jason Butler

Work Performance Price Targets & Ratings Chart

Analyst Jason Butler, carries an average stock price target met ratio of 36.14% that have a potential upside of 55.43% achieved within 211 days. Previously, Jason Butler worked at JMP.

Jason Butler’s has documented 730 price targets and ratings displayed on 52 stocks. The coverage was on Healthcare, Industrials, Consumer Cyclical, Technology sectors.

Most recent stock forecast was given on RZLT, Rezolute at 06-Oct-2026.

Wall Street Analyst Jason Butler

Analyst best performing recommendations are on ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES) at 7/14/2025. The price target of $33 was fulfilled within 9 days with a profit of $24.17 (273.73%) receiving and performance score of 304.14.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ADMS Adamas Pharmaceuticals ARGX argenx NV ADR ARNA Arena Pharmaceuticals AXGT Sio Gene Therapies CRMD CorMedix CYTK Cytokinetics ESPR Esperion Therapeutics HALO Halozyme Therapeutics ITCI Intracellular Th KRTX Karuna Therapeutics NEOS Neos Therapeutics NERV Minerva Neurosciences RZLT Rezolute SYRS Syros Pharmaceuticals VNDA Vanda Pharmaceuticals XON Precigen ZFGN Zafgen MYOV Myovant Sciences Ltd PLXP PLx Pharma AMTI Applied Molecular Transport AQST Aquestive Therapeutics ATHA Athira Pharma AXON Axon Enterprise CRTX Cortexyme ENTA Enanta Pharmaceuticals HOOK Hookipa Pharma LRMR Larimar Therapeutics PGEN Precigen GMDA Gamida Cell Ltd MRNS Marinus Pharmaceuticals CNCE Concert Pharmaceuticals MOR MorphoSys AG ADR OVID Ovid Therapeutics PRTO Proteon Therapeutics QNRX Quoin Pharmaceuticals Ltd DRC TRVN Trevena VRDN Viridian Therapeutics ZGNX Zogenix GHRS GH Research PLC PRTA Prothena plc TARA Protara Therapeutics VIGL Vigil Neuroscience IRWD Ironwood Pharmaceuticals ABVX Abivax SA American Depositary Shares AMT American Tower Corp CNC Centene Corp GM General Motors Company IT Gartner KRT Karat Packaging PL Planet Labs PBC AVTX Avalo Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Jun-2025

$36

$16.88 (88.28%)

$37

10 days ago
(08-Oct-2026)

1/10 (10%)

$16.42 (83.86%)

173

Buy Since 15-Dec-2025

$33

$13.88 (72.59%)

$37

23 days ago
(25-Sep-2026)

0/3 (0%)

$12.32 (59.57%)

Buy Since 17-Apr-2025

$34

$14.88 (77.82%)

$36

23 days ago
(25-Sep-2026)

4/6 (66.67%)

$13.32 (64.41%)

144

Buy Since 25-Sep-2025

$31

$11.88 (62.13%)

$38

23 days ago
(25-Sep-2026)

1/4 (25%)

$10.32 (49.90%)

831

Buy Since 28-Feb-2024

$35

$15.88 (83.05%)

$41

23 days ago
(25-Sep-2026)

9/15 (60%)

$14.32 (69.25%)

393

Show more analysts

Please expand the browser size to see the chart

Which stock is Jason Butler most bullish on?

Potential upside of $380.86 has been obtained for ARGX (ARGENX NV ADR)

Which stock is Jason Butler most reserved on?

Potential downside of -$28.84 has been obtained for HALO (HALOZYME THERAPEUTICS)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?